SobelJD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol, 1985; 152:924–935.
2.
MartinHL, RichardsonBA, NyangePM, et al.Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis, 1999; 180:1863–1868.
3.
TahaTE, HooverDR, DallabettaGA, et al.Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS, 1998; 12:1699–1706.
4.
LeitichH, Bodner-AdlerB, BrunbauerM, KaiderA, EgarterC, HussleinP. Bacterial vaginosis as a risk factor for preterm delivery: A meta-analysis. Am J Obstet Gynecol, 2003; 189:139–147.
5.
FettweisJM, SerranoMG, BrooksJP. The vaginal microbiome and preterm birth. Nature, 2019; 25:1012–1021.
6.
BradshawCS, MortonAN, HockingJ, et al.High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis, 2006; 193:1478–1486.
7.
AllsworthJE, PeipertJF. Prevalence of bacterial vaginosis: 2001–2004 national health and nutrition examination survey data. Obstet Gynecol, 2007; 109:114–120.
8.
FredricksDN, FiedlerTL, MarrazzoJM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med, 2005; 353:1899–1911.
9.
ShaBE, ChenHY, WangQJ, et al.Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol, 2005; 43:4607–4612.
10.
BautersTG, DhontMA, TemmermanMI, NelisHJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gyncol, 2002; 187:569–574.
11.
WellsJS, ChandlerR, DunnA, BrewsterG. The vaginal microbiome in U.S. Black women: A systematic review. J Womens Health, 2020; 29:362–375.
12.
Zozaya-HinchliffeM, LillisR, MartinDH. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol, 2010; 48:1812–1819.
13.
GajerP, BrotmanRM, BaiG, et al.Temporal dynamics of the human vaginal microbiota. Sci Transl Med, 2012; 4:132.
14.
DiGiulioDB, CallahanBJ, McMurdiePJ, et al.Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci, 2015; 112:11060–11065.
15.
RomeroR, HassanSS, GajerP. The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome, 2014; 2:1–19.
16.
MulheisenAL, Herbst-KralovetzMM. Menopause and the vaginal microbiome. Maturitas, 2016; 91:42–50.
17.
LewisFM, BernsteinKT, AralSO. Vaginal microbiome and its relationship to behavior, sexual health, and sexually transmitted diseases. Obstet Gynecol, 2017; 129:643–654.
18.
RiggsM, KlebanoffM, NanselT, ZhangJ, SchwebkeJ, AndrewsW. Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age. Sex Transm Dis, 2007; 34:954–959.
19.
BermanHL, McLarenMR, CallahanBJ. Understanding and interpreting community sequencing measurements of the vaginal microbiome. Br J Obstet Gynaecol, 2020; 127:139–146.
20.
RavelJ, GajerP, AbdoZ, et al.Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci, 2011; 108:4680–4687.
21.
ShipitsynaE, RoosA, DatcuR, et al.Composition of the vaginal microbiota in women of reproductive age—Sensitive and specific molecular diagnosis of bacterial vaginosis is possible?. PLoS One, 2013; 8:4.
22.
MaB, FranceM, CrabtreeJ, et al.VIRGO, a comprehensive non-redundant gene catalog, reveals extensive within community intraspecies diversity in the human vagina. Nat Commun, 2020; 11:940.
23.
VerstraelenH, Vieira-BaptistaP, De SetaF, VentoliniG, Lonnee-HoffmannR, Lev-SagieA. The vaginal microbiome: I. research development, lexicon, defining “normal” and the dynamics throughout women's lives. J Low Genit Tract Dis, 2022; 26:73–78.
